Literature DB >> 25502961

Cognitive improvement in meningioma patients after surgery: clinical relevance of computerized testing.

Ikram Meskal1, Karin Gehring, Sophie D van der Linden, Geert-Jan M Rutten, Margriet M Sitskoorn.   

Abstract

Cognitive dysfunction is common in patients with primary brain tumors, and may have a major impact on activities of daily living and on quality of life. This is the first prospective study that investigated the incidence and severity of cognitive dysfunction in meningioma patients before and after surgery, and the change in dysfunction over time, both at group and individual patient level. Sixty-eight meningioma patients were neuropsychologically tested one day before brain surgery. Sixty-two patients were followed up 3 months after surgery. All patients were assessed with a brief (30 min) computerized screening battery of neuropsychological tests (i.e., CNS Vital Signs). Pre- and post-operatively, meningioma patients demonstrated significantly lower scores in all cognitive domains; memory, psychomotor speed, reaction time, complex attention, cognitive flexibility, processing speed, and executive functioning, in comparison with normative data. Pre-operatively, 47 out of 68 patients (69 %) scored low or very low in one or more cognitive domains. Post-operatively, 27 out of 62 patients (44 %) scored within this range. Test performance improved in all cognitive domains post-operatively, with the exception of psychomotor speed and reaction time. In line with previous studies with conventional neuropsychological tests, meningioma patients are faced with cognitive dysfunction in several cognitive domains both pre- and post-operatively. However, a large proportion of patients shows post-operative improvement in cognitive functioning. Longer-term follow-up is recommended to identify potential predictors of cognitive improvement after surgery. Diagnosis and treatment of these cognitive deficits will improve outcomes and quality of life in meningioma patients.

Entities:  

Mesh:

Year:  2014        PMID: 25502961     DOI: 10.1007/s11060-014-1679-8

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  17 in total

1.  Reliability and validity of a computerized neurocognitive test battery, CNS Vital Signs.

Authors:  C Thomas Gualtieri; Lynda G Johnson
Journal:  Arch Clin Neuropsychol       Date:  2006-10-02       Impact factor: 2.813

2.  A power primer.

Authors:  J Cohen
Journal:  Psychol Bull       Date:  1992-07       Impact factor: 17.737

3.  The hospital anxiety and depression scale.

Authors:  R P Snaith; A S Zigmond
Journal:  Br Med J (Clin Res Ed)       Date:  1986-02-01

4.  Cognitive deficits in patients with trigeminal neuralgia: opportunities to improve care and quality of life.

Authors:  Ikram Meskal; Geert-Jan M Rutten; Guus N Beute; Miriam E Salden; Margriet M Sitskoorn
Journal:  Acta Neurochir (Wien)       Date:  2014-05-09       Impact factor: 2.216

5.  Differential effect of surgery and radiotherapy on neurocognitive functioning and health-related quality of life in WHO grade I meningioma patients.

Authors:  David van Nieuwenhuizen; Martin Klein; Lukas J A Stalpers; Sieger Leenstra; Jan J Heimans; Jaap C Reijneveld
Journal:  J Neurooncol       Date:  2007-04-13       Impact factor: 4.130

6.  Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial.

Authors:  Karin Gehring; Margriet M Sitskoorn; Chad M Gundy; Sietske A M Sikkes; Martin Klein; Tjeerd J Postma; Martin J van den Bent; Guus N Beute; Roelien H Enting; Arnoud C Kappelle; Willem Boogerd; Theo Veninga; Albert Twijnstra; Dolf H Boerman; Martin J B Taphoorn; Neil K Aaronson
Journal:  J Clin Oncol       Date:  2009-05-26       Impact factor: 44.544

7.  Does familiarity with computers affect computerized neuropsychological test performance?

Authors:  Grant L Iverson; Brian L Brooks; V Lynn Ashton; Lynda G Johnson; C Thomas Gualtieri
Journal:  J Clin Exp Neuropsychol       Date:  2008-10-29       Impact factor: 2.475

8.  Late neurocognitive sequelae in patients with WHO grade I meningioma.

Authors:  M Dijkstra; D van Nieuwenhuizen; L J A Stalpers; M Wumkes; M Waagemans; W P Vandertop; J J Heimans; S Leenstra; C M Dirven; J C Reijneveld; M Klein
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-07-24       Impact factor: 10.154

9.  Neurocognitive functioning and health-related quality of life in patients with radiologically suspected meningiomas.

Authors:  D van Nieuwenhuizen; N Ambachtsheer; J J Heimans; J C Reijneveld; S M Peerdeman; M Klein
Journal:  J Neurooncol       Date:  2013-05-03       Impact factor: 4.130

10.  Cognitive function of patients with brain tumor in pre- and postoperative stage.

Authors:  Yoshihiko Yoshii; Daisuke Tominaga; Kouichi Sugimoto; Yukihiro Tsuchida; Akio Hyodo; Hirokatsu Yonaha; Sukemitsu Kushi
Journal:  Surg Neurol       Date:  2008-01
View more
  24 in total

1.  The relationship of cognitive performance to concurrent symptoms, cancer- and cancer-treatment-related variables in women with early-stage breast cancer: a 2-year longitudinal study.

Authors:  Debra E Lyon; Ronald Cohen; Huaihou Chen; Debra L Kelly; Angela Starkweather; Hyo-Chol Ahn; Colleen K Jackson-Cook
Journal:  J Cancer Res Clin Oncol       Date:  2016-04-21       Impact factor: 4.553

Review 2.  Cognitive Impairment Associated with Cancer: A Brief Review.

Authors:  J Cara Pendergrass; Steven D Targum; John E Harrison
Journal:  Innov Clin Neurosci       Date:  2018-02-01

3.  A missing piece? Neuropsychiatric functioning in untreated patients with tumors within the cerebellopontine angle.

Authors:  Simone Goebel; Hubertus Maximilian Mehdorn
Journal:  J Neurooncol       Date:  2018-07-07       Impact factor: 4.130

4.  Cognitive outcomes in meningioma patients undergoing surgery: individual changes over time and predictors of late cognitive functioning.

Authors:  Sophie J M Rijnen; Ikram Meskal; Marjan Bakker; Wouter De Baene; Geert-Jan M Rutten; Karin Gehring; Margriet M Sitskoorn
Journal:  Neuro Oncol       Date:  2019-07-11       Impact factor: 12.300

5.  Neurocognition in individuals with incidentally-identified meningioma.

Authors:  Alissa M Butts; Stephen Weigand; Paul D Brown; Ronald C Petersen; Clifford R Jack; Mary M Machulda; Jane H Cerhan
Journal:  J Neurooncol       Date:  2017-05-25       Impact factor: 4.130

6.  Prevalence of perceived cognitive dysfunction in survivors of a wide range of cancers: results from the 2010 LIVESTRONG survey.

Authors:  John E Schmidt; Ellen Beckjord; Dana H Bovbjerg; Carissa A Low; Donna M Posluszny; Amy E Lowery; Mary Amanda Dew; Stephanie Nutt; Sarah R Arvey; Ruth Rechis
Journal:  J Cancer Surviv       Date:  2015-08-04       Impact factor: 4.442

7.  Surgery in elderly patients with intracranial meningioma: neuropsychological functioning during a long term follow-up.

Authors:  Andrea Di Cristofori; Barbara Zarino; Giulio Bertani; Marco Locatelli; Paolo Rampini; Giorgio Carrabba; Manuela Caroli
Journal:  J Neurooncol       Date:  2018-01-12       Impact factor: 4.130

Review 8.  A systematic review of cognitive function in patients with glioblastoma undergoing surgery.

Authors:  Rohitashwa Sinha; Jade Marie Stephenson; Stephen John Price
Journal:  Neurooncol Pract       Date:  2019-04-23

9.  Long-term neurocognitive, psychological, and return to work outcomes in meningioma patients.

Authors:  Angela Sekely; Konstantine K Zakzanis; Donald Mabbott; Derek S Tsang; Paul Kongkham; Gelareh Zadeh; Kim Edelstein
Journal:  Support Care Cancer       Date:  2022-01-18       Impact factor: 3.359

10.  EANO guideline on the diagnosis and management of meningiomas.

Authors:  Roland Goldbrunner; Pantelis Stavrinou; Michael D Jenkinson; Felix Sahm; Christian Mawrin; Damien C Weber; Matthias Preusser; Giuseppe Minniti; Morten Lund-Johansen; Florence Lefranc; Emanuel Houdart; Kita Sallabanda; Emilie Le Rhun; David Nieuwenhuizen; Ghazaleh Tabatabai; Riccardo Soffietti; Michael Weller
Journal:  Neuro Oncol       Date:  2021-11-02       Impact factor: 13.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.